Compare SKM & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKM | FMS |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | South Korea | Germany |
| Employees | N/A | 108165 |
| Industry | Telecommunications Equipment | Misc Health and Biotechnology Services |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 11.6B |
| IPO Year | 1999 | N/A |
| Metric | SKM | FMS |
|---|---|---|
| Price | $38.43 | $21.65 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 2.0M | 727.1K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | 1.46% | ★ 2.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.41 | N/A |
| Revenue Next Year | $1.85 | $3.83 |
| P/E Ratio | $31.64 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.66 | $20.02 |
| 52 Week High | $40.49 | $30.46 |
| Indicator | SKM | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 44.98 |
| Support Level | $35.86 | $21.26 |
| Resistance Level | $40.49 | $23.89 |
| Average True Range (ATR) | 1.37 | 0.43 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 61.99 | 57.65 |
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.